Trials / Completed
CompletedNCT03155724
QP ExCELs: MultiPole Pacing (MPP) Sub-Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Biotronik, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this MultiPole Pacing (MPP) sub-study of the QP ExCELs study is to demonstrate that the MPP feature is effective by converting a percentage of cardiac resynchronization therapy (CRT) non-responders to responders. The MPP sub-study is a single-arm, multi-center, prospective trial within the ongoing QP ExCELs study (NCT02290028).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MultiPole Pacing | CRT non-responders are programmed with MultiPole pacing ON. |
Timeline
- Start date
- 2017-05-19
- Primary completion
- 2020-01-23
- Completion
- 2020-01-23
- First posted
- 2017-05-16
- Last updated
- 2021-03-08
- Results posted
- 2021-03-08
Locations
44 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03155724. Inclusion in this directory is not an endorsement.